Vertex Pharmaceuticals (VRTX) Net Income Growth (5y) (2014 - 2026)
Vertex Pharmaceuticals (VRTX) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57% |
| Dec 31, 2025 | 14.54% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | 4.29% |
| Mar 31, 2025 | 1.40% |
| Dec 31, 2024 | 9.38% |
| Sep 30, 2024 | 78.61% |
| Jun 30, 2024 | -72.87% |
| Mar 31, 2024 | 32.56% |
| Dec 31, 2023 | -8.68% |
| Sep 30, 2023 | 51.80% |
| Jun 30, 2023 | 34.73% |
| Mar 31, 2023 | 25.22% |
| Dec 31, 2022 | 51.62% |
| Sep 30, 2022 | 39.05% |
| Jun 30, 2022 | 91.87% |
| Mar 31, 2022 | 25.02% |
| Dec 31, 2021 | 94.37% |
| Sep 30, 2021 | 88.10% |
| Jun 30, 2021 | 30.97% |